Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Cancers
|
September 9, 2022
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles
Tomonori Araki, Kensuke Hamada, Aung Bhone Myat, et al.
Journal of Oncology
|
June 13, 2012
Retrospective Study of Selective Submandibular Neck Dissection versus Radical Neck Dissection for N0 or N1 Necks in Level I Patients with Oral Squamous Cell Carcinoma
Yuta Yanai, Tsuyoshi Sugiura, Ikumi Imajyo, et al.
ACS Applied Materials & Interfaces
|
August 11, 2017
Anion-Exchange Membrane Fuel Cells with Improved CO<sub>2</sub> Tolerance: Impact of Chemically Induced Bicarbonate Ion Consumption
Yu Katayama, Kosuke Yamauchi, Kohei Hayashi, et al.
General Thoracic and Cardiovascular Surgery Cases
|
November 9, 2024
Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report
Takahiro Enjoji, Shinichiro Kobayashi, Kohei Hayashi, et al.
Therapeutic Advances in Medical Oncology
|
April 29, 2026
Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)
Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
Scientific Reports
|
January 27, 2025
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)
Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, et al.
International Journal of Cancer
|
August 1, 2025
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid
Tomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Nature
|
November 22, 2017
Discovery of a big void in Khufu's Pyramid by observation of cosmic-ray muons
Kunihiro Morishima, Mitsuaki Kuno, Akira Nishio, et al.
Oncology
|
October 20, 2024
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies
Tomonori Araki, Machiko Kawahira, Mototsugu Shimokawa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Cancers
|
September 9, 2022
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles
Tomonori Araki, Kensuke Hamada, Aung Bhone Myat, et al.
Journal of Oncology
|
June 13, 2012
Retrospective Study of Selective Submandibular Neck Dissection versus Radical Neck Dissection for N0 or N1 Necks in Level I Patients with Oral Squamous Cell Carcinoma
Yuta Yanai, Tsuyoshi Sugiura, Ikumi Imajyo, et al.
ACS Applied Materials & Interfaces
|
August 11, 2017
Anion-Exchange Membrane Fuel Cells with Improved CO<sub>2</sub> Tolerance: Impact of Chemically Induced Bicarbonate Ion Consumption
Yu Katayama, Kosuke Yamauchi, Kohei Hayashi, et al.
General Thoracic and Cardiovascular Surgery Cases
|
November 9, 2024
Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report
Takahiro Enjoji, Shinichiro Kobayashi, Kohei Hayashi, et al.
Therapeutic Advances in Medical Oncology
|
April 29, 2026
Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)
Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
Scientific Reports
|
January 27, 2025
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)
Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, et al.
International Journal of Cancer
|
August 1, 2025
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid
Tomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Nature
|
November 22, 2017
Discovery of a big void in Khufu's Pyramid by observation of cosmic-ray muons
Kunihiro Morishima, Mitsuaki Kuno, Akira Nishio, et al.
Oncology
|
October 20, 2024
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies
Tomonori Araki, Machiko Kawahira, Mototsugu Shimokawa, et al.
Page
of 4